Beginning Cash: The amount of cash reported by the company on its previous statement.
Immix Biopharma, Inc. (IMMX) had Beginning Cash of $93.93M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-11.56M |
|
-- |
|
-- |
|
$12.46M |
|
$-12.46M |
|
$0.91M |
|
$-11.54M |
|
$-11.54M |
|
$-11.56M |
|
$-11.56M |
|
$-11.56M |
|
$-11.56M |
|
$-12.46M |
|
$-12.33M |
|
63.77M |
|
63.77M |
|
$-0.18 |
|
$-0.18 |
|
| Balance Sheet Financials | |
$233.79M |
|
$2.36M |
|
$5.32M |
|
$239.11M |
|
$9.30M |
|
-- |
|
$0.89M |
|
$10.19M |
|
$228.92M |
|
$228.92M |
|
$228.92M |
|
71.54M |
|
| Cash Flow Statement Financials | |
$-21.56M |
|
$-2.13M |
|
$155.25M |
|
|
Beginning Cash |
$93.93M |
$225.49M |
|
$131.56M |
|
$1.55M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
25.13 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-21.62M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-5.05% |
|
-5.05% |
|
-4.83% |
|
-5.05% |
|
$3.20 |
|
$-0.34 |
|
$-0.34 |
|